Home -> Law Blog Directory -> Personal Injury Law Blogs -> A Georgia Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: A Georgia LawyerFDA News: Rituxan
Genentech has informed healthcare professionals of revisions to prescribing information for Rituxan regarding a case of progressive multifocal leukoencephalopathy (PML) leading to death in a patient with rheumatoid arthritis who received Rituxan in a long-term safety extension clinical study. PML is a brain infection and had already been noted on Rituxan's label as a possible risk.
The patient developed a JC virus infection with resultant PML and death 18 months after taking the last dose of Rituxan.
Healthcare professionals treating patients with Rituxan should consider PML in any patient presenting with new onset neurologic manifestations. Additionally, consultation with a neurologist, brain MRI and lumbar puncture should be considered as clinically indicated.
You can find the Dear Doctor letter here. (PDF)
Full post as published by A Georgia Lawyer on September 22, 2008 (boomark / email).
Rituxan
FDA Reviews Cancer Medication Associated with PML
Murphy City, TX
$255,000 settlement in controversial pedophile news program case.
Newspaper Employees
Chinese Daily News must pay $5.19 million class action settlement for failing to pay overtime.

Cancer drug Rituxan fails in clinical trials, creators say
Genetech Updating Rituxan Label After Patient Death
The United Nations News Centre
Genentech Stock Soars Upon Prelim Approval of Avastin







